These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


145 related items for PubMed ID: 6505679

  • 1. Inhibitors of lysosomal enzymes: accumulation of lipofuscin-like dense bodies in the brain.
    Ivy GO, Schottler F, Wenzel J, Baudry M, Lynch G.
    Science; 1984 Nov 23; 226(4677):985-7. PubMed ID: 6505679
    [Abstract] [Full Text] [Related]

  • 2. Lipofuscin-like substances accumulate rapidly in brain, retina and internal organs with cysteine protease inhibition.
    Ivy GO, Kanai S, Ohta M, Smith G, Sato Y, Kobayashi M, Kitani K.
    Adv Exp Med Biol; 1989 Nov 23; 266():31-45; discussion 45-7. PubMed ID: 2486158
    [Abstract] [Full Text] [Related]

  • 3. Ultrastructural observations on neuronal lipofuscin (age pigment) and dense bodies induced by a proteinase inhibitor, leupeptin, in rat hippocampus.
    Nunomura A, Miyagishi T.
    Acta Neuropathol; 1993 Nov 23; 86(4):319-28. PubMed ID: 8256581
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Metabolism of leupeptin and its effect on autophagy in the perfused rat liver.
    Aronson NN, Dennis PA, Dunn WA.
    Acta Biol Med Ger; 1981 Nov 23; 40(10-11):1531-8. PubMed ID: 7342603
    [Abstract] [Full Text] [Related]

  • 6. Leupeptin causes an accumulation of lipofuscin-like substances in liver cells of young rats.
    Ivy GO, Kanai S, Ohta M, Sato Y, Otsubo K, Kitani K.
    Mech Ageing Dev; 1991 Mar 23; 57(3):213-31. PubMed ID: 2056777
    [Abstract] [Full Text] [Related]

  • 7. Morphological changes in cultured myotubes treated with agents that interfere with lysosomal function.
    Bursztajn S, Libby P.
    Cell Tissue Res; 1981 Mar 23; 220(3):573-88. PubMed ID: 7296646
    [Abstract] [Full Text] [Related]

  • 8. Routes of excretion of neuronal lysosomal dense bodies after ventricular infusion of leupeptin in the rat: a study using ubiquitin and PGP 9.5 immunocytochemistry.
    Cavanagh JB, Nolan CC, Seville MP, Anderson VE, Leigh PN.
    J Neurocytol; 1993 Sep 23; 22(9):779-91. PubMed ID: 8270961
    [Abstract] [Full Text] [Related]

  • 9. Morphological, physiological and biochemical alterations in livers of rodents induced by protease inhibitors: a comparison with old livers.
    Kitani K, Ohta M, Kanai S, Nokubo M, Sato Y, Otsubo K, Ivy GO.
    Adv Exp Med Biol; 1989 Sep 23; 266():75-92. PubMed ID: 2486165
    [Abstract] [Full Text] [Related]

  • 10. Protease inhibitors as a model for NCL disease, with special emphasis on the infantile and adult forms.
    Ivy GO.
    Am J Med Genet; 1992 Feb 15; 42(4):555-60. PubMed ID: 1376968
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of the lysosomal pathway of protein degradation in isolated rat hepatocytes by ammonia, methylamine, chloroquine and leupeptin.
    Seglen PO, Grinde B, Solheim AE.
    Eur J Biochem; 1979 Apr 02; 95(2):215-25. PubMed ID: 456353
    [No Abstract] [Full Text] [Related]

  • 12. Ultrastructural studies on autolysosomes in rat hepatocytes after leupeptin treatment.
    Ishikawa T, Furuno K, Kato K.
    Exp Cell Res; 1983 Mar 02; 144(1):15-24. PubMed ID: 6840200
    [Abstract] [Full Text] [Related]

  • 13. Appearance of autolysosomes in rat liver after leupeptin treatment.
    Furuno K, Ishikawa T, Kato K.
    J Biochem; 1982 May 02; 91(5):1485-94. PubMed ID: 6178729
    [Abstract] [Full Text] [Related]

  • 14. Lysosomotropic agents induce morphological and functional changes in human muscle cells in vitro.
    Baron PL, Meola G, Scarpini E, Moggio M, Santilli I, Scarlato G.
    Eur J Basic Appl Histochem; 1991 May 02; 35(4):423-32. PubMed ID: 1801935
    [Abstract] [Full Text] [Related]

  • 15. Leupeptin causes an accumulation of lipofuscin-like substances and other signs of aging in kidneys of young rats: further evidence for the protease inhibitor model of aging.
    Ivy GO, Roopsingh R, Kanai S, Ohta M, Sato Y, Kitani K.
    Ann N Y Acad Sci; 1996 Jun 15; 786():12-23. PubMed ID: 8687013
    [Abstract] [Full Text] [Related]

  • 16. Reversible accumulation of lipofuscin-like inclusions in the retinal pigment epithelium.
    Katz ML, Rice LM, Gao CL.
    Invest Ophthalmol Vis Sci; 1999 Jan 15; 40(1):175-81. PubMed ID: 9888441
    [Abstract] [Full Text] [Related]

  • 17. Degeneration of neuronal processes in rats induced by a protease inhibitor, leupeptin.
    Takauchi S, Miyoshi K.
    Acta Neuropathol; 1989 Jan 15; 78(4):380-7. PubMed ID: 2782049
    [Abstract] [Full Text] [Related]

  • 18. Effect of leupeptin on the autophagic vacuolar system of rat hepatocytes. Correlation between ultrastructure and degradation of membrane and cytosolic proteins.
    Henell F, Glaumann H.
    Lab Invest; 1984 Jul 15; 51(1):46-56. PubMed ID: 6330453
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of lipofuscinogenesis: effect of the inhibition of lysosomal proteinases and lipases under varying concentrations of ambient oxygen in cultured rat neonatal myocardial cells.
    Marzabadi MR, Sohal RS, Brunk UT.
    APMIS; 1991 May 15; 99(5):416-26. PubMed ID: 2043354
    [Abstract] [Full Text] [Related]

  • 20. Proteolysis of connexin43-containing gap junctions in normal and heat-stressed cardiac myocytes.
    Laing JG, Tadros PN, Green K, Saffitz JE, Beyer EC.
    Cardiovasc Res; 1998 Jun 15; 38(3):711-8. PubMed ID: 9747439
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.